急性缺血性卒中后联合口服甘油三酯和葡萄糖耐量试验预测复发性血管事件:柏林「Cream&Sugar」研究
该前瞻性观察研究在德国柏林夏里特大学医学院3个院区纳入755例首次缺血性卒中患者,于卒中后3至7天行口服甘油三酯耐量试验(OTTT)及口服葡萄糖耐量试验,评估1年复发性卒中及复合血管终点。结果显示空腹甘油三酯或血糖水平与1年复发性卒中无关,但餐后甘油三酯较高与复发性血管事件风险较低相关(校正HR 0.42,95%CI 0.18-0.95),结论不支持常规联合OTTT/OGTT改善复发性卒中风险预测。
要点
- 空腹甘油三酯或血糖水平与1年复发性卒中无关联。
- 餐后甘油三酯最高四分位组与最低四分位组相比,复发性血管事件风险较低(校正HR 0.42,95%CI 0.18-0.95)。
- 结果不支持常规使用联合OTTT/OGTT来改善复发性卒中风险预测。
核心结论
- 在首次轻型缺血性卒中患者队列中,空腹甘油三酯或血糖水平与卒中后1年复发性卒中无关。
- 较高的餐后甘油三酯水平与复发性血管事件风险较低相关,需在未来研究中进一步验证。
- 总体结果不支持常规使用联合OTTT/OGTT来改善复发性卒中的风险预测。
研究设计与样本
- 前瞻性观察性柏林「Cream&Sugar」研究,在德国柏林夏里特大学医学院3个不同大学医院院区进行,时间为2009年1月24日至2017年7月31日。
- 共纳入755例首次缺血性卒中患者,于卒中后3至7天招募;523例患者完成OTTT和1年随访。
- 空腹患者行OTTT,并在OTTT前(t0)及OTTT后3小时(t1)、4小时(t2)、5小时(t3)连续采血;所有非糖尿病患者在OTTT开始后3小时行口服葡萄糖耐量试验。
- 研究结局为复发性致死或非致死性卒中,以及包括卒中、短暂性脑缺血发作、心肌梗死、冠状动脉血运重建和心血管死亡的复合血管终点,于卒中后1年评估。
- 采用Cox回归模型估计甘油三酯和血糖水平高与低患者之间的风险比及相应95%CI。
主要发现
- 患者以轻型卒中为主,美国国立卫生研究院卒中量表评分中位数为1(0-3)。
- 比较甘油三酯水平最高四分位组与最低四分位组,空腹甘油三酯水平(校正HR t0,1.24 [95%CI,0.45-3.42])和餐后甘油三酯水平(校正HR t3,0.44 [95%CI,0.16-1.25])均与复发性卒中无关。
- 关于复发性血管事件,空腹甘油三酯结果相似(校正HR t0,1.09 [95%CI,0.49-2.43]),但较高的餐后甘油三酯水平与复发性血管事件风险较低显著相关(校正HR t3,0.42 [95%CI,0.18-0.95])。
- 空腹血糖和口服葡萄糖耐量试验后血糖水平与复发性血管风险之间未观察到关联。
- 所有发现与患者的糖尿病状态无关。
临床怎么用
- 原文结论指出,总体结果不支持常规使用联合OTTT/口服葡萄糖耐量试验来改善复发性卒中的风险预测。
局限性
- 较高的餐后甘油三酯水平与复发性血管事件风险较低相关,需在未来研究中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated triglyceride and glucose levels are associated with an increased cardiovascular disease risk including ischemic stroke. It is not known whether the response to a combined oral triglyceride and glucose challenge after ischemic stroke improves identification of patients with increased risk for recurrent vascular events. METHODS: The prospective, observational Berlin "Cream&Sugar" study was conducted at 3 different university hospital sites of the Charité-Universitätsmedizin Berlin, Germany, between January 24, 2009 and July 31, 2017. Patients with first-ever ischemic stroke were recruited 3 to 7 days after stroke. An oral triglyceride tolerance test (OTTT) and consecutive blood tests before (t0) as well as 3 (t1), 4 (t2), and 5 hours (t3) after OTTT were performed in fasting patients. An oral glucose tolerance test was performed in all nondiabetic patients 3 hours after the start of OTTT. Outcomes of the study were recurrent fatal or nonfatal stroke as well as a composite vascular end point including stroke, transient ischemic attack, myocardial infarction, coronary revascularization, and cardiovascular death assessed 1 year after stroke. Cox regression models were used to estimate hazard ratios and corresponding 95% CIs between patients with high versus low levels of triglyceride and glucose levels. RESULTS: Overall 755 patients were included; 523 patients completed OTTT and 1-year follow-up. Patients were largely minor strokes patients with a median National Institutes of Health Stroke Scale score of 1 (0-3). Comparing highest versus lowest quartiles of triglyceride levels, neither fasting (adjusted hazard ratiot0, 1.24 [95% CI, 0.45-3.42]) nor postprandial triglyceride levels (adjusted hazard ratiot3, 0.44 [95% CI, 0.16-1.25]) were associated with recurrent stroke. With regard to recurrent vascular events, results were similar for fasting triglycerides (adjusted hazard ratiot0, 1.09 [95% CI, 0.49-2.43]), however, higher postprandial triglyceride levels were significantly associated with a lower risk for recurrent vascular events (adjusted hazard ratiot3, 0.42 [95% CI, 0.18-0.95]). No associations were observed between fasting and post-oral glucose tolerance test blood glucose levels and recurrent vascular risk. All findings were irrespective of the diabetic status of patients. CONCLUSIONS: In this cohort of patients with first-ever' minor ischemic stroke, fasting triglyceride or glucose levels were not associated with recurrent stroke at one year after stroke. However, higher postprandial triglyceride levels were associated with a lower risk of recurrent vascular events which requires further validation in future studies. Overall, our results do not support the routine use of a combined OTTT/oral glucose tolerance test to improve risk prediction for recurrent stroke.
引用
- Nave AH, Kaynak N, Mai K, et al. Combined Oral Triglyceride and Glucose Tolerance Test After Acute Ischemic Stroke to Predict Recurrent Vascular Events: The Berlin "Cream&Sugar" Study. Stroke. 2022. PMID: 35531780. doi:10.1161/STROKEAHA.122.038732
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。